AHL
AMGN icon

Abel Hall LLC’s Amgen AMGN Stock Holding History

Abel Hall LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Sell
1,570
-861
-35% -$295K 0.1% 199
2026
Q1 		$855K Buy
2,431
+1,460
+150% +$520K 0.18% 92
2025
Q4 		$318K Buy
971
+184
+23% +$58.4K 0.07% 307
2025
Q3 		$222K Buy
+787
New +$228K 0.09% 246
2025
Q2 		– Sell
-744
Closed -$232K – 293
2025
Q1 		$232K Buy
+744
New +$220K 0.14% 140

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Abel Hall LLC's AMGN Position: Q2 2026 in Review

Abel Hall LLC reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $295K and leaving 1,570 shares worth $569K. The position accounts for 0.1% of the portfolio, ranked #199.

Abel Hall LLC first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $855K in Q1 2026. 1,282 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Abel Hall LLC held 1,570 shares of Amgen worth $569K as of Q2 2026.
  • Abel Hall LLC sold 861 Amgen shares in Q2 2026, an estimated $295K.
  • Amgen made up 0.1% of Abel Hall LLC's portfolio in Q2 2026, its #199 holding.
  • Abel Hall LLC first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • Abel Hall LLC's Amgen position peaked at $855K in Q1 2026.
  • 1,282 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.